A harmonized medial temporal lobe subregion segmentation protocol: an essential element for dementia research

协调一致的内侧颞叶亚区域分割协议:痴呆症研究的基本要素

基本信息

  • 批准号:
    10574500
  • 负责人:
  • 金额:
    $ 69.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

The hippocampus and the parahippocampal region of the medial temporal lobe (MTL) consist of anatomically and functionally distinct subregions that are selectively targeted by different pathological processes in neurodegenerative disorders, such as Alzheimer’s disease (AD) and semantic variant Primary Progressive Aphasia (svPPA). In AD, in vivo MRI studies investigating MTL subregions have often shown mixed findings that are inconsistent with post-mortem pathology studies. These inconsistencies likely result from the lack of validity and standardization in MTL segmentation approaches. In svPPA, MTL subregions are severely affected, and automated tools fail to segment the subregions accurately. Sufficient spatial resolution of imaging voxels is required to visualize the internal MTL structures and landmarks that are critical for valid segmentation of the subregions. While more than 15,000 high-resolution scans have been collected worldwide, the lack of standardization among MTL subregional segmentation protocols is still a significant barrier. Variability in the definition of the MTL subregional boundaries among existing segmentation protocols have contributed to the conflicting findings in the field. This proposal seeks to accelerate progress made by our group, the Hippocampal Subfields Group, and complete our standardized, valid, and reliable harmonized protocol for the segmentation of MTL subregions in high-resolution MRI scans. We will leverage our ongoing, successful efforts, and evaluate the proposed harmonized protocol in scans from multicentric datasets. In Aim 1, we will finalize our harmonized segmentation protocol that is a) based on a large histology dataset and developed in collaboration with neuroanatomists, b) assessed by the larger community to reach consensus, c) tested for reliability, and d) implemented in an existing automated software program. In Aim 2, we will validate the harmonized protocol in early-stage AD through associations with markers of specific pathologies: a) test for anatomical specificity of the associations between atrophy rates across MTL subregions to PET measures of MTL tau-pathology and markers of cardiovascular risk in patients with Mild Cognitive Impairment and cerebral β-amyloid. In Aim 3, we will further evaluate the validity and utility of the harmonized protocol in svPPA by performing manual segmentation of the MTL subregions using the HSG protocol and testing for anatomical specificity of volume atrophy. In Aim 4, we will facilitate wide adoption of our protocol by providing training and education materials, in-person workshops for manual and automated segmentation, and making outcome measures publicly available. Our valid, reliable, and reproducible protocol for MTL subregions segmentation will benefit groups worldwide that have and continue to collect thousands of high-resolution data to study a variety of neurological and psychiatric conditions. It also lays the foundation for future research on how distinct disease processes in the MTL subregions may lead to impairments in specific cognitive functions. Our harmonization process can be adapted for achieving valid, harmonized segmentation for other brain regions.
海马和内侧颞叶(MTL)的海马旁区由以下组成: 在解剖学和功能上不同的亚区,其被不同的病理学选择性靶向, 神经退行性疾病,如阿尔茨海默氏病(AD)和语义变异过程 进行性失语症(svPPA)。在AD中,研究MTL亚区的体内MRI研究经常显示 与死后病理学研究不一致的混合结果。这些不一致可能导致 MTL分割方法缺乏有效性和标准化。在svPPA中,MTL子区域是 受影响严重,自动化工具无法准确划分次区域。足够的空间分辨率 的成像体素,以可视化的内部MTL结构和标志,这是关键的有效 分区域划分。虽然在全球范围内收集了超过15,000个高分辨率扫描, MTL分区域分割协议之间缺乏标准化仍然是一个重大障碍。 在现有的分割协议中,MTL次区域边界的定义存在差异, 导致了实地调查结果的矛盾这项建议旨在加快我们的进展, 组,海马子域组,并完成我们的标准化,有效,可靠的协调 在高分辨率MRI扫描中分割MTL子区域的协议。我们将利用我们正在进行的, 成功的努力,并评估所提出的协调协议在扫描多中心数据集。在Aim中 1,我们将最终确定我们的协调分割协议,该协议是a)基于大型组织学数据集, 与神经解剖学家合作开发,B)由更大的社区评估以达成共识,c) 测试可靠性,以及d)在现有的自动化软件程序中实现。在目标2中,我们将验证 通过与特定病理学标志物的关联,在早期AD中的协调方案: MTL亚区萎缩率与PET测量之间相关性的解剖学特异性 轻度认知障碍和脑卒中患者MTL tau病理学和心血管风险标志物 β-淀粉样蛋白在目标3中,我们将通过以下方式进一步评估协调协议在svPPA中的有效性和实用性: 使用HSG协议对MTL子区域进行手动分割,并测试解剖结构 体积萎缩的特异性。在目标4中,我们将通过提供培训和 教育材料,人工和自动细分的现场研讨会,并取得成果 公开的措施。我们的有效,可靠和可重复的MTL子区域分割协议 将使世界各地的团体受益,这些团体已经并将继续收集数千个高分辨率数据,以研究 各种神经和精神疾病。这也为未来研究如何区分 MTL亚区域的疾病过程可能导致特定认知功能的损伤。我们 协调过程可以适于实现针对其他大脑区域的有效的、协调的分割。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rosanna Kathleen Olsen其他文献

Rosanna Kathleen Olsen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rosanna Kathleen Olsen', 18)}}的其他基金

A harmonized medial temporal lobe subregion segmentation protocol: an essential element for dementia research
协调一致的内侧颞叶亚区域分割协议:痴呆症研究的基本要素
  • 批准号:
    10392166
  • 财政年份:
    2022
  • 资助金额:
    $ 69.22万
  • 项目类别:
RECOGNITION MEMORY: NEURAL CORRELATES OF ITEM MEMORY STRENGTH
识别记忆:项目记忆强度的神经关联
  • 批准号:
    8169875
  • 财政年份:
    2010
  • 资助金额:
    $ 69.22万
  • 项目类别:
RECOGNITION MEMORY: NEURAL CORRELATES OF ITEM MEMORY STRENGTH
识别记忆:项目记忆强度的神经关联
  • 批准号:
    7955401
  • 财政年份:
    2009
  • 资助金额:
    $ 69.22万
  • 项目类别:
HIGH-RESOLUTION FMRI OF THE MEDIAL TEMPORAL LOBE DURING DELAYED-MATCH-TO-SAMPLE
延迟匹配样本期间内侧颞叶的高分辨率 FMRI
  • 批准号:
    7722923
  • 财政年份:
    2008
  • 资助金额:
    $ 69.22万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.22万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了